Tribal Opioid Response
ID: 349687Type: Posted
Overview

Buyer

Substance Abuse and Mental Health Services Adminis (HHS-SAMHS-SAMHSA)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349687

Additional Information

https://www.samhsa.gov/grants/grant-announcements/ti-24-009
Timeline
    Description

    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a grant opportunity titled "Tribal Opioid Response" aimed at addressing the opioid overdose crisis in Tribal communities. This program seeks to enhance access to FDA-approved medications for the treatment of opioid use disorder (MOUD) and to support a comprehensive range of services including prevention, harm reduction, treatment, and recovery support for opioid use disorder (OUD) and co-occurring substance use disorders. The grant is particularly significant as it targets federally recognized American Indian or Alaska Native Tribes and tribal organizations, allowing them to apply individually, as a consortium, or in partnership with Urban Indian Organizations. The total estimated funding for this program is $63 million, with awards ranging from $0 to $1.75 million, and a total of approximately 130 awards expected. Interested applicants should note that the application deadline is July 1, 2024, and can reach out to the Office of Financial Resources at SAMHSA via email at FOACSAT@samhsa.hhs.gov or by phone at (240) 276-1940 for further information.

    Point(s) of Contact
    FOACSAT@samhsa.hhs.gov
    Files
    No associated files provided.
    Similar Opportunities
    Rural Opioid Technical Assistance Regional Centers
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Rural Opioid Technical Assistance Regional Centers." This program aims to establish regional centers of excellence that will provide training and technical assistance to combat opioid and stimulant misuse in rural communities. The initiative is crucial for addressing the growing health crisis related to substance abuse in these areas, with an estimated total program funding of $7,150,000 and the expectation of awarding 11 grants. Interested applicants, including public or nonprofit entities, states, Indian tribes, and health facilities, can reach out to Twyla Adams at (240) 276-1576 or via email at twyla.adams@samhsa.hhs.gov for further information. The opportunity is currently posted, with an estimated synopsis posting date of May 1, 2025.
    Tribal Behavioral Health
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Tribal Behavioral Health," aimed at preventing and reducing suicidal behavior and substance use among American Indian/Alaska Native (AI/AN) youth, up to age 24. This program seeks to build a supportive network of systems, services, and partnerships to promote mental health and address the impacts of trauma within these communities. With an estimated total program funding of $7,861,000 and the expectation of awarding 31 grants, eligibility is limited to federally recognized AI/AN tribes, tribal organizations, Urban Indian Organizations, or consortia of tribes or tribal organizations. Interested applicants can reach out to Kathleen Burkhart at kathleen.burkhart@samsha.hhs.gov or (240) 276-1313 for further information, with the synopsis expected to be posted on November 15, 2024.
    Provider’s Clinical Support System – Medication Assisted Treatment Grant
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Provider’s Clinical Support System – Medication Assisted Treatment Grant" aimed at expanding training for primary care providers in the prevention and treatment of opioid use disorders (OUD) and chronic pain management. This grant seeks to enhance understanding and access to medication-assisted treatment (MAT) through the training of providers authorized to prescribe FDA-approved schedule III medications for addictive disorders, specifically targeting national professional medical organizations such as ASAM, AAAP, AMA, AOAAM, and APA. With an estimated total program funding of $2,000,000 and the expectation of one award, interested applicants can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further details. The synopsis for this opportunity is expected to be posted on February 15, 2022.
    First Responders – Comprehensive Addiction and Recovery Act
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "First Responders – Comprehensive Addiction and Recovery Act," aimed at supporting first responders and key community members in administering emergency treatments for opioid overdoses. This program is designed to enhance the capacity of eligible entities, including states, local governments, and tribal organizations, to utilize approved drugs or devices for the rapid reversal of opioid overdoses, addressing a critical public health issue. With an estimated total program funding of $5.1 million and an expected 12 awards, interested applicants can reach out to Shannon Hastings at (240) 276-1869 or via email at DTPFRCARA@samhsa.hhs.gov for further information. The synopsis for this opportunity is anticipated to be posted on November 15, 2024, with no cost-sharing or matching requirements.
    Addiction Technology Transfer Centers Cooperative Agreement
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Addiction Technology Transfer Centers Cooperative Agreement" aimed at enhancing the behavioral healthcare and primary healthcare workforce for substance use disorder (SUD) treatment and recovery support services. This initiative seeks to accelerate the adoption of evidence-based practices, improve workforce knowledge and skills, and foster collaborations among diverse stakeholders in the field of substance use and co-occurring health disorders. With an estimated total program funding of $8.6 million and an expected 12 awards, eligible applicants include states, territories, Indian tribes, and nonprofit entities. Interested parties can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further information, with the synopsis expected to be posted on January 30, 2023.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications that support a diverse range of preclinical and clinical projects, with the goal of advancing medication studies toward FDA approval, emphasizing the importance of innovative approaches to drug misuse and addiction treatment. Eligible applicants include a variety of institutions, such as higher education entities and community organizations, with funding available up to $5 million per year for projects lasting up to three years. Interested parties can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by August 11, 2025.
    Targeted Capacity Expansion – Special Projects
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Targeted Capacity Expansion – Special Projects," aimed at enhancing the provision of substance use disorder (SUD) and co-occurring disorder (COD) services for under-resourced populations. The program seeks to implement targeted strategies for harm reduction, treatment, and recovery support services to address unmet community needs. With an estimated total program funding of $8 million and the expectation of awarding 21 grants, this initiative is crucial for improving health outcomes in communities facing substance use challenges. Interested applicants, which include domestic public and private nonprofit entities, can reach out to Angelica Ramirez at angelica.ramirez@samhsa.hhs.gov or (240) 276-1581 for further information, with the synopsis expected to be posted on November 15, 2024.
    Assisted Outpatient Treatment Program for Individuals with Serious Mental Illness
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Assisted Outpatient Treatment Program for Individuals with Serious Mental Illness." This program aims to implement and evaluate new Assisted Outpatient Treatment (AOT) programs, focusing on evidence-based practices to reduce psychiatric hospitalizations, homelessness, and interactions with the criminal justice system, while enhancing health and social outcomes for individuals with serious mental illness (SMI). The grant is particularly significant as it addresses critical health challenges faced by vulnerable populations, with an estimated total funding of $2 million available for three expected awards. Interested applicants, including states, counties, and mental health systems, can reach out to Katie Hager at katie.hager@samhsa.hhs.gov or (240) 276-1268 for further information, with the synopsis expected to be posted on December 16, 2024.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity for the development of medications aimed at preventing and treating substance use disorders (SUDs) and overdose. This initiative is structured into two phases: the UG3 phase focuses on achieving specific milestones within a two-year period, while the UH3 phase extends support for an additional three years for projects that successfully meet the UG3 milestones. Given the urgent need for effective treatments in light of rising overdose deaths, particularly from synthetic opioids and stimulants, this funding opportunity emphasizes innovative research methodologies and the effective application of existing medications. Interested applicants can seek funding of up to $3 million annually for a maximum of five years, with applications due by August 11, 2025. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-329.html.